ICON Accounting Probe

ICON accounting probe found revenue overstatements, withdrew FY2025 guidance and delayed Q4 results to April 30, 2026, raising near-term uncertainty.

February 12, 2026·2 min read
View all news articles
Flat vector of a lab server module with a cracked shell symbolizing the ICON accounting probe and reporting risk.

KEY TAKEAWAYS

  • Audit Committee opened an accounting probe into fiscal years 2023-2025 revenue recognition.
  • Company withdrew FY2025 guidance and delayed fourth-quarter results to on or before April 30, 2026.
  • Preliminary review flagged revenue overstated by less than 2% annually and expected material weaknesses.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

ICON plc (ICLR) said in a Feb. 12, 2026, press release that an internal accounting probe launched in late October 2025 found preliminary revenue overstatements. The company withdrew its fiscal 2025 guidance and delayed fourth-quarter results to on or before April 30, 2026.

Audit Committee Investigation and Controls

The investigation is led by ICON’s Audit Committee, which engaged outside legal counsel and forensic and technical accounting advisers after management raised concerns. The review focuses on revenue recognition and related internal controls over financial reporting for fiscal years 2023 through 2025.

Preliminary findings indicate revenue for fiscal 2023 and 2024 may have been overstated by less than 2% annually, with no impact on customers identified. ICON expects to report one or more material weaknesses in its internal controls over financial reporting and is implementing corrective actions to strengthen those controls.

Earnings Delay and Shareholder Probes

ICON issued fiscal 2025 guidance on Oct. 22, 2025, projecting revenue between $8.05 billion and $8.10 billion and adjusted diluted earnings per share of $13.00 to $13.20. The company reported fiscal 2024 revenue of $8.282 billion and fiscal 2023 revenue of $8.12 billion.

Following the Feb. 12 disclosure, multiple shareholder law firms, including Hagens Berman, Ademi LLP, Johnson Fistel, and Rosen Law, have opened investigations into potential securities claims. The withdrawal of guidance, expected material weaknesses, and these probes raise the possibility of a financial restatement and shareholder litigation.

ICON plans to report its fourth-quarter and full-year 2025 results by April 30, 2026. Those filings will determine whether the preliminary findings require accounting corrections and could increase legal risks.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Applied Materials Earnings Rise on AI Demand

Applied Materials Earnings Rise on AI Demand

Applied Materials earnings beat as AI-processor demand and services revenue lifted profit and pushed Q2 guidance above estimates lifting afterhours shares.

Coinbase Q4 Earnings Show Operational Strength

Coinbase Q4 Earnings Show Operational Strength

Coinbase Q4 earnings showed $5.2 trillion volume and rising subscriptions, but a brief service disruption and analyst downgrades clouded market reaction.

AST SpaceMobile Convertible Notes Offering

AST SpaceMobile Convertible Notes Offering

AST SpaceMobile convertible notes offering and concurrent repurchases reshape near-term capital plans and could alter equity supply and debt cost.

QuantumScape Earnings Misses Estimates

QuantumScape Earnings Misses Estimates

QuantumScape earnings missed expectations as the company guided $250-$275 million adjusted-EBITDA loss and $40-$60 million CapEx, tightening runway.

Nebius Q4 2025 Results Show AI Growth

Nebius Q4 2025 Results Show AI Growth

Nebius Q4 2025 results showed AI-cloud growth lifted ARR to $1.25 billion while a $2.06 billion capex surge widened the loss and weighed on traders.

Zoetis Q4 2025 Results Beat Estimates

Zoetis Q4 2025 Results Beat Estimates

Zoetis Q4 2025 results showed a beat and raised 2026 guidance, prompting traders to favor companion-animal and international exposure over U.S. softness.